Skip to main content
. 2019 Feb 27;24(5):846. doi: 10.3390/molecules24050846

Figure 4.

Figure 4

Variability of matrix metalloproteinases (MMP) by groups: (a) MMP-2, (b) MMP-C = control; STZ-C = streptozotocin control; STZ + CC1 = STZ and 1 mg/100 g bw CC as pre-treatment; STZ + CC2 = STZ and 2 mg/100 g bw CC as pre-treatment; STZ + lCC1 = STZ and pre-treatment with 1 mg/100 g bw lCC; STZ + lCC2 = STZ and pre-treatment with 2 mg/100 g bw lCC. a p-values < 0.002 as compared to STZ-C group excepting a1 0.0181 and a2 0.0088; b p-values as compared to STZ + CC1 group of 0.0017 excepting b1 0.1797 andb2 0.0027; c p-values as compared to STZ + CC2 group < 0.002 excepting c1 0.0553 and c2 0.0027; d p-value as compared to STZ + lCC1 group of 0.0017 excepting d1 0.0845.